We are colonized from birth by myriads of microbes in and on our body that constitute our microbiome. Numerous studies have shown that the composition and activity of our microbiome in various body sites are associated with health and disease.
The programme will feature acknowledged experts from the UK and NL, who will provide an update on the state of the art of the microbiome, varying from its development in early life and its impact on immune programming, disease risk and host interactions to its modulation by diet and specific pharmaceutical or microbial therapies. There will be ample time for questions and discussion.
Programme 10 May
- Rooms: the Tinbergen room and its foyers Carolina MacGillavry + Willem Enthoven
- Moderators: Willem de Vos (Sessions one and two) and Elaine Holmes (Session three)
Welcome
9.00 a.m.
Registration, coffee and tea
9.30 a.m.
Jos van der Meer, Chair of Section of Medicine KNAW and Professor of Internal Medicine, Radboud University and Tom Solomon Chair of Neurology and Director of the National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections at the University of Liverpool and an Associate Pro-Vice-Chancellor in the Faculty of Health and Life Sciences – Welcome to the symposium
Session One
9.40 a.m.
Willem de Vos, Professor of Human Microbiomics at the University of Helsinki and Distinguished Professor at the Wageningen University and Elaine Holmes, Professor of Chemical Biology in the Department of Surgery and Cancer at Imperial College, in London, UK – Introduction to the symposium
9.50 a.m.
Clara Belzer, Assistant Professor at the Laboratory of Microbiology, Department of Agrotechnology and Food Sciences at Wageningen University & Research – The early-life microbiome
10.20 a.m.
Julie McDonald, Lecturer, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London – Microbiome and disease risk
10.50 a.m.
General discussion
Session Two
11.10 a.m.
Petra Louis, Senior Research Fellow, Microbiology Group, Rowett Institute, University of Aberdeen – Diet and the microbiome
11.40 a.m.
Patrick Varga Weisz, Senior Lecturer, School of Life Sciences, University of Essex – Chromatin dynamics and host-microbiome interaction in the gut
12.10 p.m.
Joost Wiersinga, Professor of Internal Medicine, and Translational Infectious Diseases, at the University of Amsterdam’s Faculty of Medicine (AMC-UvA) – The microbiome and immune programming
12.40 p.m.
General discussion
1.00 p.m.
Lunch
Session Three
2.30 p.m.
Willem de Vos, Professor of Human Microbiomics at the University of Helsinki and Distinguished Professor at the Wageningen University – Single microbes – case of Akkermansia
3.00 p.m.
Nordin M. J. Hanssen, Internal medicine specialist and Principal Investigator, at Amsterdam University Medical Centres – Can the gut microbiome be used to treat autoimmune diabetes?
3.30 p.m.
General discussion
3.50 p.m.
Final panel/general discussion – with overview of key messages to emerge form each session led by Willem de Vos and Elaine Holmes
4.30 p.m.
Conclusions
4.40 p.m.
Close
4.45 p.m.
Drinks
6.00 p.m.
End of symposium